LACE - Laparoscopic Approach to Cancer of the Endometrium: An International Multicenter Randomized Phase 3 Clinical Trial
This phase III international, multicenter, open-label, randomized clinical trial is an
equivalence study with the hypothesis is that Total Laparoscopic Hysterectomy (TLH) is
associated with equivalent disease-free survival when compared to the standard treatment of
Total Abdominal Hysterectomy (TAH) for women with apparent Stage I endometrial cancer.
The secondary hypotheses are:
- TLH is associated with equivalent or improved Quality of Life (QoL) at 6 months;
- TLH is associated with reduced treatment-related morbidity;
- TLH is associated with shorter hospital stay;
- TLH is associated with less analgesic consumption;
- TLH is cost effective;
- TLH is associated with improved pelvic floor function.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Disease free survival
4.5 years from surgery
No
Andreas Obermair
Principal Investigator
Queensland Centre for Gynaecological Cancer
Australia: Department of Health and Ageing Therapeutic Goods Administration
LACE001
NCT00096408
October 2005
June 2014
Name | Location |
---|